22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
New space is ideally equipped and located in the heart of Buffalo’s urban renewal 22nd Century Group, Inc Buffalo, New York, UNITED STATES
WILLIAMSVILLE, N.Y., Jan. 28, 2021 (GLOBE NEWSWIRE) 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company is moving its corporate headquarters to the up-and-coming Larkinville District in downtown Buffalo.
“We have experienced tremendous positive change in our organization over the past year and this relocation will help us improve on efficiency, collaboration, and our ability to attract and retain top talent,” said James A. Mish, chief executive officer of 22nd Century Group. “We have deep roots in Buffalo, and we are very excited to be moving
Company’s Confidence in MRTP Authorization is High; Launch of VLN® is Only the Beginning for Tobacco Franchise 22nd Century Group, Inc. (NYSE American: XXII), a
Containing 95% Less Nicotine than Traditional Cigarettes, VLN
® is the Only Combustible Tobacco Product that Complies with the FDA’s Proposed Nicotine Cap
/EIN News/ WILLIAMSVILLE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it continues to be confident on the renewal of the FDA’s proposed reduced nicotine mandate that would make all cigarettes “minimally or non-addictive.” By way of support, four former U.S. Food and Drug Administration (FDA) commissioners, Robert M. Califf, M.D. MACC; Scott Gottlieb, M.D.; Peggy Hamburg, M.D.; and, Jane Henney, M.D., spoke on a recent panel and were vocal in their endorsement of the mandate to limit the amount of nicotine in cigarettes to levels already achieved by 22nd Century’s reduced nicotine content cigarettes, VLN
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes Company will significantly increase planting in the 2021 crop year 22nd Century Group, Inc Williamsville, New York, UNITED STATES
WILLIAMSVILLE, N.Y., Jan. 12, 2021 (GLOBE NEWSWIRE) 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will significantly expand its growing program for VLN
® reduced nicotine content tobacco based on the Company’s latest sales projections. This new planting for VLN